Sponsors Rein In Clinical Trial Violation Rate, But Monitoring Is Problematic
This article was originally published in The Gray Sheet
Executive Summary
Despite improvements in sponsors' compliance with clinical trial regulations last year, trial monitoring continues to be an issue, according to CDRH